Galidesivirum

Galidesivirum Uses, Dosage, Side Effects, Food Interaction and all others data.

Galidesivirum is an adenosine analogue that has been investigated for use against Zaire Ebolavirus. In animal studies, galidesivir was effective in increasing the survival rates from infections caused by various pathogens, including Ebola, Marburg, Yellow Fever and Zika viruses. In vitro, it displayed broad-spectrum antiviral activity against various negative- and positive-sense RNA viruses, including coronaviruses, filoviruses, and arenaviruses. Phase 1 clinical trials have begun to determine the safety of this drug in humans. Because of its activity against other coronaviruses, it may be studied as a potential therapy for COVID-19.

Galidesivirum is an adenosine analogue with a broad-spectrum antiviral activity against RNA viruses, including flaviviruses, togaviruses, bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses, filoviruses, orthomyxoviruses, and picornaviruses.

Trade Name	Galidesivirum
Generic	Galidesivir
Galidesivir Other Names	Galidesivir, Galidésivir, Galidesivirum, Immucillin A, Immucillin-A
Type
Formula	C11H15N5O3
Weight	Average: 265.2685 Monoisotopic: 265.117489371
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

How Galidesivirum works

Galidesivirum works by binding to viral RNA polymerase where the natural nucleotide would bind, leading to the structural change in the viral enzyme due to altered electrostatic interactions. Disruption of viral RNA polymerase activity results in premature termination of the elongating RNA strand.

Innovators Monograph

You find simplified version here Galidesivirum